Another mechanism of resistance is attributed to the activity of alternative proangiogenic pathways, such as fibroblast growth factor (FGF) and angiopoietin-2 (ANGPT2), which can promote the creation of new blood vessels that will vascularize the tumor, resulting in its progression [24]. This evidence concerns the gene ANGPT2 and neoplasm.